Kiri

20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT Ref.: C.L.31.2026 The World Health Organization (WHO) presents its compliments to Member States and Associate Members and has the pleasure of announcing that the 49th Expert Committee on Drug Dependence (ECDD) will meet from 19 to 22 October 2026 in Geneva, Switzerland. Given that WHO Expert Committee meetings are of a closed nature, this letter serves to notify Member ... States of the Agenda of the 49th ECDD, which is in the Annex I file, attached for reference. WHO is mandated by the 1961 and 1971 International Drug Control Conventions to make recommendations to the UN Secretary-General on the need for and level of international control of psychoactive substances based on the advice of its independent scientific advisory body, the ECDD. To assess whether or not a psychoactive substance should be placed under international control, the ECDD convenes annually to review the potential of that substance to cause dependence, abuse and harm to health, as well as any therapeutic applications. In order to perform this review and make evidence-based decisions, the ECDD conducts medical, scientific, and public health evaluations of the selected psychoactive substances using the best available information. Although the meetings are of a closed nature, Member States and Associate Members are invited to contribute to the ECDD review process by joining the 49th ECDD Information Session on 19 October 2026. The Information Session will be held virtually and allow interested parties to learn about present and future activities of the ECDD Secretariat, and to present information concerning substances under review to the 49th Expert Committee for consideration in its deliberations. Registration information will be made available on the ECDD website in due course: Expert Committee on Drug Dependence. As in the past and in line with the publication “Guidance on the WHO review of psychoactive substances for international control” (EB126/2010/REC1, Annex 6),1 Member States and Associate Members can also contribute to the ECDD review process by providing up to date and accurate information concerning the substances under review in advance of the meeting. For this purpose, and as per previous practice, a questionnaire will be sent to Member States and Associate Members to gather country information on the legitimate use, harmful use, status of national control and potential impact of international control for each substance under evaluation. 1 https://apps.who.int/gb/ebwha/pdf_files/EB126-REC1/B126_REC1-en.pdf#page=90. ... ENCLS.: (2)  Page 2 C.L.31.2026 ... Annex II to this Circular Letter contains a list of national focal points officially designated by Member States and Associate Members in previous years who provide country information to the ECDD through the Member States questionnaire referred to above. If the focal point information requires changes or amendments, Member States and Associate Members are invited to inform the WHO ECDD Secretariat by email to [email protected] by 31 July 2026 with the subject “49ECDD Focal Point: (Country Name)”. If the individual on the list is still the official focal point for completing the ECDD Member State questionnaire this year and if no additions or amendments to focal point details are made by 31 July 2026, the focal point from the list will be given further instructions and direct access to online questionnaires by the WHO Secretariat. Results of the questionnaires will be prepared as a report as part of the 49th ECDD substance review process. In addition to the questionnaire, Member States and Associate Members are also encouraged to provide any additional relevant information (unpublished or published) on substances to be reviewed by the 49th ECDD by emailing [email protected] with the subject “Ref: C.L.31.2026”. All recommendations made by the 48th ECDD, held in October 2025, were accepted by the 69th UN Commission on Narcotic Drugs and all technical reports and recommendations made by the ECDD will be available online through the recently launched ECDD Information Repository (https://ecddrepository.org/en). The World Health Organization takes this opportunity to renew to Member States and Associate Members the assurance of its highest consideration. GENEVA, 9 July 2026  Annex I 49th WHO Expert Committee on Drug Dependence Provisional Agenda ---- Information Meeting (Virtual) 19 October 2026 10:00-13:00 CEST 1. Welcome and opening of the meeting 2. WHO presentations 2.1 Expert Committee on Drug Dependence 2.2 Science Division 2.3 Gender, Equity, and Human Rights 2.4 Legal and Ethics 3. Presentations and statements from participants  49th WHO Expert Committee on Drug Dependence Geneva, Switzerland Provisional Agenda ---- Closed Session 19–22 October 2026 1. Procedural matters and updates 1.1 Opening of meeting and welcoming remarks 1.2 Introduction of participants 1.3 Statement of confidentiality 1.4 Declarations of interest 1.5 Election of Chair, Vice-Chair, and Rapporteur 1.6 Adoption of agenda 2. Updates on priorities from international agencies 2.1 Briefings from international agencies on their work on the public health dimension of the world drug problem 2.1.1 WHO 2.1.2 UNODC 2.1.3 INCB 2.2 Updates on ECDD meeting recommendations and outcomes 2.2.1 Recommendations and outcomes of the 48th ECDD 2.2.2 Updates on substance surveillance 3. Critical reviews: Recommendations on the scope of international control 3.1 Cychlorphine / N-propionitrile chlorphine – critical review (Opioids) 3.2 Desalkylgidazepam – critical review (Benzodiazepine) 3.3 Ethylbromazolam – critical review (Benzodiazepine) 3.4 Etomidate – Pre-review (medicine anaesthetic) 3.5 Medetomidine – Pre-review (veterinary medicine – anaesthetic) 3.6 Etomethazene (5-methyl etodesnitazene) (Opioids) 3.7 Spirochlorphine (Opioids) 3.8 Clobromazolam (Benzodiazepines) 4. Finalization of meeting report Annex II: List of focal points designated by Member States in previous years Country Name of Focal Point Job title Institution Email Last update Afghanistan Albania Linda Ternova Specialist Regulation Sector of Pharmaceutical Market [email protected] and Medical Devices Ministry of Health and Social Protection, Albania Algeria Ghrieb Houria Doctor Narcotics, Psychotropics and Chemical [email protected] Precursors, General Direction of Pharmacy and Health Equipment, Algerian Health Ministry Andorra Carla Lobaco Valls Technical Officer Department of Health Resources and Medicines [email protected] Andorra Carme Pallarés Papaseit Department of Health Resources and Medicines, [email protected] Angola Ana Da Conceição Mamede General Director, National Ministry of Health [email protected] Institute for combating Drugs Antigua and Barbuda Argentina G. Rebaldería Pharmacist Director of Surveillance of Substances Subject [email protected] to Special Control Argentinian Ministry of Health Armenia Hasmik Martirosyan Armenian Ministry of Health [email protected] Australia Narcotics Control Section [email protected] 7/10/2024 Office of Drug Control Australian Government Department of Health and Aged Care Australia [email protected] Austria Raphael Bayer Head of Division Section VI, Department 6 raphael.bayer@gesundheitsminister Federal Ministry of Social Affairs, Health, Care ium.gv.at and Consumer Protection Azerbaijan Telman Suleyman Oglu [email protected] Mammadhassanov Country Name of Focal Point Job title Institution Email Last update Bahamas Bahrain Samar Yousef Salem Senior Pharmacist Ministry of Health [email protected] Bangladesh Habibur Rahman Khan Additional Secretary Health Services Division, [email protected] Ministry of Health & Family Welfare Barbados Lindsay Bynoe Assistant Director for Drug Ministry of Health [email protected] Regulation Belarus Aleksey Kralko Ministry of Health [email protected] Belgium Lies Gremeaux Head of Unit illicit Drugs, Epidemiology and Public Health, Sciensano, [email protected] Reitox National Focal Ministry of Health Point Belize Benin Saturnin Bognon State-certified Pharmacist, Pharmaceutical Establishments Department [email protected] Head of Pharmaceutical Establishments Department Bhutan Dil Kumar Subba Department of Public Health, Ministry of Health [email protected] Bolivia Permanente Representative of the Plurinational [email protected]; 7/27/2024 H.E. Amb. Maira Mariela (Plurinational State of Bolivia [email protected] Macdonal State of) Bosnia and [email protected]; Herzegovina [email protected] Bosnia and Sabina Šahman Department for Health, Ministr of the Civill [email protected] Herzegovina Affairs of Bosnia and Herzegovina Botswana Vivian Sebako Chief Pharmacist Department of Clinical Services, Ministry of [email protected] Health and Wellness Brazil Renata de Morais Souza, Manager Management of Controlled Products [email protected] Moema Luisa Silva Macedo GPCON/GGMON/DIMON/ANVISA Controlled Substances Office Brazilian Health Regulatory Agency – ANVISA Country Name of Focal Point Job title Institution Email Last update Brazil Natalia Jorge e Costa International Affairs Office, Brazilian Health [email protected] Regulatory Agency - ANVISA, AINTE/ GADIP/ANVISA Brunei Hajah Zanatul ‘Aini Haji Acting Director of Department of Pharmaceutical Services, [email protected] Darussalam Zainin (Ms) Pharmaceutical Services Ministry of Health Bulgaria Slaveyka Nikolova Chief Expert at the Health Department Health Promotion and Prophylaxis [email protected] Promotion of the Diseases and Addictions Directorate Bulgaria Alexander Panayotov Head of the National Mental Health and Addiction Prevention [email protected] Focus Center Department Directorate, National Center for Public Health and Analysis Burkina Faso [email protected] Burundi Israël Nimubona [email protected] Cabo Verde Raquel Lopes Commission for the Coordination of Alcohol [email protected] 8/30/2024 and Other Drugs, Ministerio da Saude e da Seguranca Social Cambodia Chhit Sophal Director Department of Mental and Substance Abuse, [email protected] Ministry of Health Cameroon Ketchozo Loko Wilfried [email protected] Canada International Relations Unit, Office of Drug [email protected] 4/26/2024 Policy and Science, Controlled Substances Directorate, Health Canada, Government of Canada Central African Republic Chad Haoua Haroun Saker Deputy Director of Ministry of Public Health [email protected] Pharmacy and Medicine Chile Javiera Erazo Leiva Advisor Department of Mental Health/DIPRECE, [email protected] Ministry of Health Country Name of Focal Point Job title Institution Email Last update China Zhendong HUA Deputy Director National Narcotics Laboratory [email protected] China Yan ZHENG Official Office of National Narcotics Control [email protected] Commission China Peng XU Senior Expert National Narcotics Laboratory [email protected] Colombia Oscar Ricardo Santana Observatorio de Drogas de Colombia [email protected]; 7/16/2024 Dirección de Políticas de Drogas y Actividades [email protected] Relacionadas Ministerio de Justicia y del Derecho Colombia Nubia Esperanza Bautista Coordinadora del Grupo Dirección de Promoción y Prevención – [email protected] Convivencia Social y Ministerio de Salud y Protección Social Ciudadanía Colombia Germán Andrés Calderón Coordinador Grupo Ministerio de Relaciones Exteriores [email protected] Velásquez Interno de Trabajo de o; Asuntos Relacionados con [email protected] las Drogas v.co Comoros Cook Islands Tereapii Uka Central Policy and Planning Office [email protected] Costa Rica Marchena Vasquez [email protected] Côte d'Ivoire Ernest Zotoua [email protected] Croatia Lidija Vugrinec Head of National Croation Institute of Public Health [email protected] 8/30/2024 Information Unit in the Field of Drugs and Behavioural Addictions and Internal Relations Department Cuba Cyprus John Kkolos Pharmacist Pharmaceutical Services, Ministry of Health [email protected] Czechia Vlastimil Brandejs Inspectorate Department, Narcotic and [email protected] Psychotropic Substances Ministry of Health Country Name of Focal Point Job title Institution Email Last update Democratic Kim Jong Guk People's Republic of Korea Democratic Ghislaine Mbelu Kanyunya [email protected] Republic of the Congo Denmark Kari Gragaasen Chief Consultant Head of Focal Point, Prevention, National [email protected] Board of Health Djibouti Dominica Laura Esprit Chief Medical Office Ministry of Health, Wellness and New Health [email protected] Investment Dominica Anna Royer-Edmund Chief Pharmacist Ministry of Health, Wellness and New Health [email protected] Investment m Dominican [email protected] Republic Dominican Francisca Dalia Castillo Head of the Assistive General Directorate of Medicines, Food and [email protected] Republic Sanchez Technology Department Health Products (DIGEMAPS), Ministry of ob.do Public Health Ecuador Gabriel Ordonez Guzman Director nacional de Salud Mental Y Fenomeno Socioeconomico de [email protected] 7/24/2024 Estrategias de Prevencion las Drogas Y Control para Enfermedades no Transmisibles Egypt Dr Samah Abdeleazik Kandil Ministry of Health and Population [email protected]; 7/16/2024 [email protected] El Salvador José Mauricio Bermúdez Focal Point of the Ministry Health Technology Department, [email protected] Recinos of Health of El Salvador Ministry of Health Equatorial Guinea Eritrea Michael Girmay Haile [email protected] Country Name of Focal Point Job title Institution Email Last update Estonia Olga Kamp Inspector of State Agency of Medicines, Ministry of Health [email protected] pharmacovigilance, drugs and psychotropic substances, and the precursors Eswatini Ethiopia Baharu Zewdie Moya [email protected] Fiji Ilisabeta May Pesamino Chief Pharmacist Pharmaceutical & Biomedical Services/Ministry [email protected] of Health & Medical Services Finland Katja Pihlainen Finnish Medicines Agency, Ministry of Health [email protected] France Luciano Amato Acting Head of Regulation of narcotics and psychotropic [email protected] Department substances, National Agency for the Safety of Medicines and Health Products Gabon Okouyi Ndakissa Directorate of Medicines and Pharmacy [email protected] Ministry of Health Gambia Georgia Ekaterine Paposhvili Senior Specialist Division of Legal Circulation of Narcotic [email protected] Drugs, LEPL State Regulation Agency for Medical Activities Ministry of Labour, Health and Social Affairs of Georgia Germany Annette Hinze Division 122 - Narcotics Law, Traffic in [email protected] Narcotics, International Narcotic Drug Affairs Federal Ministry of Health Ghana Martha Gyansa-Lutterodt Director Pharmaceutical Services, Ministry of Health [email protected] Country Name of Focal Point Job title Institution Email Last update Greece Dr Foteini Koulouri Head of General Hellenic Ministry of Health [email protected] ; 7/16/2024 Directorate of Public [email protected] Health and Quality of Life Greece Avgerinos Nikolaos Psychiatrist, Programs OKANA - Organisation Against Drugs Greece [email protected]; Implementation Director [email protected] Greece Ms Anastasia Petroulia Legal Advisor to the Hellenic Ministry of Health [email protected]; Will also Minister of Health [email protected] attend the 47th ECDD meeting Grenada Guatemala José Miguel Solares Estrada Department of Regulation [email protected] 8/30/2024 and Control of Related Pharmaceutical Products Guatemala Alicia Elena Morgan Durán Section of Psychotropics, [email protected] 8/30/2024 Narcotics, Imports and Exports Guinea Guinea-Bissau Guyana Haiti Marie Judith Robuste Roche Ministry of Health [email protected] Honduras Alex Virgilio Santos Moreno General Director of the Honduran Institute for the Prevention of [email protected] Honduran Institute for the Alcoholism, Drug Addiction and Drug Prevention of Alcoholism Dependence (IHADFA) Hungary Tímea Kahlesz Deputy Head of EMMI Pharmaceutical and Medical Technology [email protected] Department Department Iceland Bjarni Sigurðsson Ministry of Health [email protected] India Dr Anju Dhawan Professor and Head Department of Psychiatry, National Drug Anju Dhawan 7/24/2024 Dependence Treatment Centre, All India <[email protected]> Institute of Medical Sciences Country Name of Focal Point Job title Institution Email Last update Indonesia Agusdini Banun Saptaningsih Director of Pharmaceutical Directorate General of Pharmaceutical Care and [email protected] Production and Medical Devices, Distribution Iran (Islamic Mina Azhoogh [email protected] Republic of) Iraq Emad Abdulrazzaq Ministry of Health [email protected] Abdulghani Ireland Conor Brennan Department of Health [email protected] Ireland Alan Bell Department of Health [email protected] Israel Paola Rosca Head of the Addiction Ministry of Health [email protected] Treatment Department Israel Tal Lavy The Competent Authority for Narcotics, [email protected] Psychotropics and Precursors Pharmaceutical Administration Italy Pietro Canuzzi Head of Office 7, Central Ministry of Health - Directorate general of [email protected] 7/26/2024 Narcotic Office Health Prevention Jamaica Dr Jacquiline Bisasor Chief Medical Officer Ministry of Health & Wellness [email protected] 7/5/2024 McKenzie Jamaica Ms Uki Atkinson Research Analyst National Council on Drug Abuse (NCDA) [email protected] 7/5/2024 Japan Compliance and Narcotics Division, [email protected] Pharmaceutical Safety and Environmental Health Bureau Jordan Malak AlMahirah Head of Narcotics, Psychotropic Substances and [email protected] Chemical Precursors Department, Jordan Food and Drug Administration Kazakhstan Prilutskaya Marina Republican Scientific and Practical Center of [email protected] Mental Health Kenya Anthony Toroitich [email protected] Kenya Simon Njuguna [email protected] Kiribati Biribo Kararaiti Chief Pharmacist Ministry of Health and Medical Services [email protected] Country Name of Focal Point Job title Institution Email Last update Kuwait Ali Abdulmohsen Jaragh Head Control of Licenses for Narcotic Drugs and [email protected] 7/24/2024 Psychotropic Substances Department Kyrgyzstan Kanyshai Damirbek Drug Trafficking Control Department, [email protected] Ministry of Foreign Affairs Lao People's Khatthanaphone Phandoangsy Head of Health Promotion Department of Hygiene and Health Promotion, [email protected] Democratic and Nutrition Unit Ministry of Health Republic Latvia Linda Veisberga Ministry of Health [email protected] Lebanon Marie-Therese Matar Head of Narcotics Ministry of Public Health [email protected] Department Lesotho Masello Sello [email protected] Liberia Dr. Moses Ziah II Director Mental Health Ministry of Health, Republic of Liberia [email protected]; Unit [email protected] Libya Lithuania Rima Mačiūnienė Head of Drug Precursors Drug Precursors Control and Risk Assessment [email protected] Control and Risk Division, Assessment Division Drug, Tobacco and Alcohol Control Department Luxembourg Alain Origer National Drug Coordinator Ministry of Health [email protected] Madagascar Maximine Ravaoarimanana Director of Pharmacy Laboratories and Traditional Medicine [email protected]; [email protected] Malawi Michael Udedi Assistant Director of [email protected] Clinical Services (Mental Health and Substance Abuse) Malaysia Rohaida Binti Zakaria Senior Principal Assistant Pharmaceutical Services Division, Ministry of [email protected] Director Health Maldives Aishath Mohamed Deputy Director General, Medicine and Therapeutic Goods Division, [email protected] Pharmaceuticals Maldives Food and Drug Authority Mali Mahamadou Ousmane Maiga [email protected] Country Name of Focal Point Job title Institution Email Last update Malta Victor P. Pace Office of the Superintendence of Public Health, [email protected] Department for Health Regulation Marshall Julia Alfred Ministry of Health [email protected] Islands Mauritania Hamoud Fadel Yamohomed Director of Pharmacy and Ministry of Health [email protected] Laboratories Mauritius Nitish Raj Sokool Officer-in-Charge Harm Reduction Unit, Ministry of Health and [email protected] Wellness Mauritius Anil Jhugroo Advisor on Substance Ministry of Health and Wellness [email protected] Abuse Mexico Angélica Juárez Ramírez Specialized Reviewer COFEPRIS representative, Federal Committee [email protected] for Protection from Sanitary Risks Micronesia Benido Victor [email protected] (Federated States of) Monaco Isabelle Kessedjian Head of Division Pharmacy Inspector, Health Products Division [email protected] Mongolia Luvsandagva Purevdorj [email protected] Montenegro Jasna Sekulic Ministry of Health [email protected] Morocco Hassan Elkarimi [email protected] Morocco Jallal Toufiq Professor of Psychiatry, [email protected] Rabat Faculty of Medicine, Director of the National Centre on Drug Abuse Prevention, Treatment and Research, Director of the Moroccan Observatory on Drugs and Drugs Addictions Mozambique Flavio Mandlate [email protected] Country Name of Focal Point Job title Institution Email Last update Myanmar Nanda Myo Aung Wan Program Manager/ Drug Dependency Treatment and Research [email protected] Consultant Psychiatrist Unit, Ministry of Health and Sport Namibia Ester Mvula Senior Pharmacist Ministry of Health & Social Services [email protected] Nauru Richard Leona Chief Surgeon Ministry of Health [email protected] Nepal Netherlands Matthijs Geilenkirchen Nutrition, Health Protection and Prevention [email protected] 29 April Department, 2024 Ministry of Health, Welfare and Sport New Zealand Group mail to be cc'ed [email protected] 7/10/2024 New Zealand Tania Jones Regulatory Practice and Analysis, [email protected] confirmed Medsafe 10/7/24 Nicaragua Karla Vanessa Delgado Director of Pharmacy Ministry of Health [email protected] Martinez Niger Haoua Na Allah Alou [email protected] Nigeria Wosilat Abdulhameed Deputy Director Federal Ministry of Health [email protected] 8/30/2024 Niue North Macedonia Norway Anne S. Onsgård Sagabråten Narcotic Drugs Control, [email protected] Norwegian Medicines Agency Oman Dr. Mohammed Al-Rubaie, [email protected] 7/10/2024 Oman Dr Mahmood Al Abri [email protected] 7/10/2024 Oman Directorate General of Pharmaceutical Affairs [email protected] and Drug control, Ministry of Health Oman Drug Safety Center, Ministry of Health, [email protected] 8/30/2024 Sultanate of Oman Pakistan Rizwan Taj Professor Ministry of Health [email protected] Country Name of Focal Point Job title Institution Email Last update Palau Clarette Matlab Chief Pharmacist Division of Ancillary Services, [email protected] Bureau of Hospital and Clinical Services, Ministry of Health Palau [email protected] Palau Marla Ito [email protected] Panama Dr Ricardo Goti, Coordinateur du Ministère de la Santé du Panama [email protected] 7/16/2024 Programme de Santé Mentale Papua New Vicky Wari Program Manager-Non Public Health Division, National Department of [email protected] Guinea Communicable Diseases Health Paraguay Blanca Galeano [email protected] 8/30/2024 Paraguay Zaira Francesca Stumpfs [email protected] Bigarella Peru Judith Castañeda Alcántara Head of Functional Unit of DIGEMID – General Directorate of Medicines, [email protected] 7/26/2024 Controlled Products Supplies and Drugs Philippines Poland Michał Kidawa Polish Reitox Focal Point Information Centre for Drugs and Drug [email protected] Addiction (CINN) National Bureau for Drug Prevention Portugal Graça Vilar Director of Planning and Intervention Service for Addictive Behaviours [email protected] Intervention Services and Addictions Directorate General Directorate for Intervention on Addictive Behaviours and Dependencies SICAD Puerto Rico Qatar Majid Ali Al Abdulla Senior Consultant Director of addiction and CL at Hamad Medical [email protected] Psychiatrist Corporation Deputy Chairman of Mental Health Services, Hamad Medical Corporation Republic of Sang Hun Yeon Narcotics Policy Division of Ministry of Food [email protected] 7/16/2024 Korea and Drug Safety Country Name of Focal Point Job title Institution Email Last update Republic of Oleg Costachi Standing Committee on Drugs Control, [email protected] Moldova Agency for Medicines and Medical Devices Romania Camelia Bunaciu Senior Advisor Ministry of Health [email protected] Russian Alyona Ryzova Deputy Head of the Unit Department for regulation of medicines and [email protected] 7/11/2024 Federation for regulatory and legal medical devices, regulation of Ministry of Health pharmaceutical activities, regulation of narcotic drugs and psychotropic substances Rwanda Saint Kitts and puerto rico Nevis Saint Lucia Charlotte Emmanuel Coordinator of the Substance Abuse Advisory Council Secretariat, [email protected] Substance Abuse Advisory Ministry of Health and Wellness Council Secretariat Saint Lucia Paul Caleb Programme Officer Substance Abuse Advisory Council Secretariat, [email protected] Ministry of Health and Wellness Saint Vincent and the Grenadines Samoa Robert Thomsen Assistant Chief Executive HSPQA, Medical and Allied Division [email protected] Officer San Marino Claudio Muccioli Health Authority Director Health Authority [email protected] Sao Tome and Principe Saudi Arabia Adnan Alshammary Administration of controlled preparations, [email protected] Executive Management for Regulatory Affairs, Controlled Products Department, Regulatory Affairs Directorate, Drug Sector Country Name of Focal Point Job title Institution Email Last update Senegal Moussa DIALLO Pharmacist Inspector Pharmaceutical Regulatory Agency, [email protected] Ministry of Health and Social Action Serbia Nataša Savić Monitoring Centre for Drugs and Drug [email protected] Addiction, Sector for Medicines and Medical Devices, Psychoactive Controlled Substances and Precursors, Ministry of Health Seychelles Sierra Leone Singapore Ong Lay Tin Personal Assistant to Senior Executive (International Cooperation) [email protected] 04/07/2024 Director (International Public Health Group, confiming Cooperation) Ministry of Health no changes Slovakia Peter Koreň Reitox National Focal National Monitoring Centre for Drugs, [email protected] 04/07/2024 Point Department of Anti-Drug Strategy Coordination confirming and Drug Monitoring, no changes Ministry of Health of the Slovak Republic Slovenia Joze Hren Secretary Directorate of Public Health, Ministry of Health [email protected] Solomon Paul Orotaloa Head of Mental Health National Mental Health Service, Ministry of [email protected] Islands Services Health and Medical Services Solomon Stephen Araitewa Director Mental Health National Mental Health Service, Ministry of [email protected] Islands Health and Medical Services Somalia South Africa MG Molewa Ministry of Health [email protected] South Sudan Moses Malual Deng Director General of Ministry of Health [email protected] Pharmaceuticals and Medical Supplies Spain Manuel Ibarra Head of Department Spanish Agency of Medicines and Medical [email protected] Inspection & Enforcement Products (AEMPS) Spain Lidia Fernandez Matellano Narcotics and Psychotropic Substances Area, [email protected] Pharmaceutical Inspection and Enforcement Department, Country Name of Focal Point Job title Institution Email Last update Spanish Agency of Medicines and Medical Products (AEMPS) Sri Lanka S.C. Wickramasinghe Deputy Director General Ministry of Health [email protected] (NCD) Sudan Suriname Sweden Annika Borg Ministry of Health and Social Affairs, [email protected] 4/8/2024 Division for Public Health and Health Care Switzerland Lucien Colliander Federal Department of Home Affairs, Federal [email protected] Office of Public Health, Division of International Affairs, Global Health Section Switzerland Monika Joos Head of Division Narcotics Swissmedic, Swiss Agency for Therapeutic [email protected] Products Syrian Arab Ahmed Al-Salama Mental Health Directorate, [email protected] Republic Ministry of Health Tajikistan Salim Abdulazizov [email protected] Thailand Sujinart Chantharakul Pharmacist Narcotics Control Division (Standards and [email protected] Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health Thailand Saranya Chavanich Pharmacist Narcotics Control Division (Standards and [email protected] Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health Thailand Korapin Na Ranong Expert on Narcotics Narcotics Control Division [email protected] Epidemiology Food and Drug Administration, Ministry of Public Health Thailand Raththar Benchapalanont Pharmacist Narcotics Control Division Food and Drug Administration, Ministry of Public Health Timor-Leste Soares Henriques Regulatory Affairs Pharmacovigilance and Medicine Control [email protected] Pharmacist Department, National Directorate for Country Name of Focal Point Job title Institution Email Last update Pharmaceutical and Medicines, Ministry of Health Togo Mouhoudine Yerima Centre National de Pharmacovigilance (CNPV) [email protected] [email protected] Tokelau Tonga Melenaite Mahe Principal Pharmacist Central Pharmacy and Medical Store, Old [email protected] Vaiola, Ministry of Health Trinidad and Anesa Doodnath-Siboo Principal Pharmacist Ministry of Health anesa.doodnath- Tobago [email protected] Tunisia Türkiye Elif Inci ERGONUL Head of Turkish Medicines and Medical Devices [email protected], 7/24/2024 Pharmacovigilance and Agency, Ministry of Health [email protected] Controlled Substances Department Turkmenistan Tuvalu Uganda Hafsa Lukwata Head of Mental Health and Mental Health and Control of Substance Abuse [email protected] Control of Substance Division, Abuse Ministry of Health Ukraine Deputy Director Institute of Psychiatry, Forensic Psychiatric [email protected] Examination and Drug Monitoring, Ukraine Irina Pinchuk Director Institute of Psychiatry of Taras Shevchenko [email protected] National University of Kyiv, International Technology Transfer Center - Ukraine Head of ISSUP Ukraine National Chapter Ukraine Yulia YACHNYK Clinical Psychologist Institute of Psychiatry, Taras Shevchenko [email protected] National University of Kyiv United Arab Alia Bin Hussain Head of Regulating Product & Precursor Chemicals Drug [email protected] Emirates Controlled substances Department, Ministry of Health and Prevention Country Name of Focal Point Job title Institution Email Last update United Alberto Oteo Project Manager Drugs Addiction and Inclusion Directorate, [email protected] Kingdom of Research and Surveillance Office for Health Improvement & Disparities, Great Britain Department of Health and Social Care and Northern Ireland United Suma Jairo Pharmacist Pharmaceutical Service Unit, Ministry of Health [email protected] Republic of Tanzania United States Edward Hawkins Senior Pharmacologist and Center for Drug Evaluation and research, [email protected] of America International Drug Control U.S. Food and Drug Administration Liaison Uruguay Lorena Quintana Coordinator of the Ministry of Public Health [email protected] 8/2/2024 Addiction Prevention and Treatment Program Uzbekistan Dr Azizbek Khamrakulov Head, Department of Ministry of Health [email protected] Inpatient and Specialized Care Uzbekistan Mr Zarif Ashurov Director Specialized Scientific and Mental Health [email protected] Medical Center Vanuatu Jerry Iaruel Tafea Provincial Health Lenakel Health Office, [email protected] Administrator Ministry of Health Venezuela (Bolivarian Republic of) Viet Nam Mhin Tam Nguyen Regulatory Affair Ministry of Health [email protected] Consultant Yemen Zambia Nita Besa Head Clinical Care Chainama Hospital [email protected] Zimbabwe Eneti Siyame Mental Health Manager Ministry of Health and Child Care [email protected] Saatja: "ola" <[email protected]> Teema: WHO: C.L.31.2026 (49th ECDD) Kuupäev: 2026-07-09 14:06 Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Dear Member States of the World Health Organization, Please find attached, in the six official languages, C.L.31.2026 regarding the 49th ECDD. For any further information, kindly contact [email protected] <mailto:[email protected]> Best regards, Department of Governing Bodies World Health Organization ***DO NOT RESPOND TO THIS E-MAIL. YOU WILL NOT RECEIVE A REPLY***